THE VOGEL GROUP

Lobbying for NEPHRON PHARMACEUTICALS CORPORATION · Developer and manufacturer of sterile inhalation and 503B outsourcing medication.

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · South Carolina · $50,000.00 income · posted Jul 19, 2026

Lobbying activity 1

Pharmacy

Issues relating to facility operations

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem